Labcorp has partnered with Thrive Global to launch the Thrive 5 Health Test, combining Labcorp's lab expertise with Thrive Global's behavior change methods. The test measures five key cardiometabolic health indicators to provide a comprehensive view of heart and metabolic health. Consumers receive personalized educational content and small daily habit recommendations to improve their health. This service is available through Labcorp OnDemand and aims to help people turn health data into actionable lifestyle changes.
The collaboration between Labcorp and Thrive Global to launch the Thrive 5 Health Test provides context for health-related market activity. For readers following the health sector, here is Pluang's market snapshot as of Oct 13, 2026 18:02 WIB: out of 128 priced US health stocks, 78 rose and 41 fell. Among notable movers, BioNTech SE (BNTX) traded at USD 93.03 with a 1-day change of -2.93% and a typical hold time of 60 days, Heron Therapeutics Inc (HRTX) at USD 0.40 with -2.79% change and a 36-day hold time, and Johnson & Johnson (JNJ) at USD 256.82 with -2.62% change and a 129-day hold time, with respective Pluang order activities showing a strong sell bias for HRTX and JNJ.
Existing-home sales in the U.S. increased by 1.5% month-over-month in September but declined 2.2% compared to the previous year, according to the National Association of Realtors. Sales rose in the South and West regions but fell in the Northeast and...
Columbus Marketing Experts, a digital marketing agency in Hilliard, Ohio, is expanding its local SEO services across Columbus to help service businesses improve their visibility on Google Search and Google Maps. The expansion aims to enhance local di...
Schrödinger's stock fell 5.02% to $25.91 despite co-founding Tectora, a new biopharma venture with $55 million funding targeting immune and inflammatory treatments. The company, known for its molecular modeling software, holds a market value of about...
Johnson & Johnson reported third-quarter 2026 earnings per share of $2.59, surpassing analyst estimates of $2.52, with total revenue of $25.40 billion slightly above expectations. The company saw robust growth in its pharmaceutical segment, which off...
Nvidia CEO Jensen Huang has reaffirmed his forecast that global spending on AI infrastructure will grow significantly, reaching between $3 trillion and $4 trillion by 2030. This projection highlights the massive potential and ongoing investment in AI...
